Verweise von und zu Janus kinase inhibitors
Zurück zum ArtikelVerweise von anderen Artikeln
- Abrocitinib
- Baricitinib
- Delgocitinib
- Filgotinib
- Januskinase 2
- JAK-inhibitors, atopic dermatitis
- Januskinases
- Esophageal Lichen Planus
- Lichen planus erosivus
- Chronic prurigo
- Psoriasis, therapy and pregnancy
- Ritlecitinib
- Ruxolitinib
- STING-associated vasculopathy with onset in infancy
Verweise zu anderen Artikeln
- Abrocitinib
- Acne (overview)
- Allosteric
- Alopecia areata (overview)
- Atopic dermatitis (overview)
- Baricitinib
- Biologics in dermatology
- CYP2C19 gene
- CYP2D6 gene
- CYP3A4
- Cytochrome p450 enzymes
- Delgocitinib
- Deucravacitinib
- Fedratinib
- Filgotinib
- Fluconazole
- Glucuronic acid (inci)
- Skin cancer (overview)
- Interferons
- Interleukin-10
- Interleukin-12
- Interleukin-13
- Interleukin-2
- Interleukin-23
- Interleukin-6
- Jak-stat signal path
- Januskinase 1
- Januskinase 2
- JAK-3
- Lichen planus classic type
- Merkel cell carcinoma
- Psoriatic arthritis
- Psoriasis (Übersicht)
- Rifampicin
- Ritlecitinib
- Ruxolitinib
- SOCS
- Thrombosis isolated distal
- Tnf-alpha antagonists
- Tofacitinib
- TYK2
- Tyrosine kinase 2
- Upadacitinib
- Varicella zoster virus
- Vitiligo (overview)
- Cytokines